Spots Global Cancer Trial Database for shr1020 plus docetaxel
Every month we try and update this database with for shr1020 plus docetaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer | NCT02766140 | Non Squamous No... | SHR1020 plus Do... Placebo plus Do... | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer | NCT02766140 | Non Squamous No... | SHR1020 plus Do... Placebo plus Do... | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer | NCT02766140 | Non Squamous No... | SHR1020 plus Do... Placebo plus Do... | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
